Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Acarix AB

Market Cap 30Cr 3.09Cr 2.69Cr 2.49Cr 2.33Cr 4.38Cr 291.24Cr 4.4Cr 11Cr 143.35Cr 12Cr 11Cr 497.76Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 30Cr 3.09Cr 2.69Cr 2.49Cr 2.33Cr 4.38Cr 291.24Cr 4.4Cr 11Cr 143.35Cr 12Cr 11Cr 497.76Cr EV / Sales 2026 *
15.5x
EV / Sales 2027 * 4.25x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day-1.19%
1 week-2.73%
Current month-1.97%
1 month-6.74%
3 months-13.54%
6 months-11.07%
Current year-7.09%
1 week 0.24
Extreme 0.242
0.26
1 month 0.24
Extreme 0.24
0.27
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.47
3 years 0.17
Extreme 0.1688
0.6
5 years 0.17
Extreme 0.1688
1.87
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Operating Officer 62 01/12/2009
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 50 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%-2.73%-6.04%-58.08% 3.09Cr
-1.89%-7.87%-0.47%-29.63% 1.56TCr
-2.00%-5.63%+32.66%+55.77% 156.98Cr
+0.19%+1.50%-26.66%+26.09% 111.67Cr
+4.11%-3.26%-51.23%-84.03% 93Cr
+5.56%+4.30%-14.86%-49.65% 68Cr
+0.58%-2.73%-39.57%-57.52% 55Cr
+3.24%-4.62%+35.87%-54.30% 44Cr
-1.26%-0.32%-54.06%-61.33% 38Cr
-3.12%-1.01%-24.84%-21.38% 34Cr
Average +0.71%-2.14%-14.92%-33.41% 216.79Cr
Weighted average by Cap. +0.55%-6.14%-3.64%-25.23%

Financials

2026 *2027 *
Net sales 1.91Cr 19.94L 17.38L 16.1L 15.07L 28.27L 19Cr 28.44L 74.02L 9.26Cr 74.84L 73.24L 32Cr 6.95Cr 72.55L 63.26L 58.58L 54.84L 1.03Cr 68Cr 1.03Cr 2.69Cr 34Cr 2.72Cr 2.66Cr 117Cr
Net income -2.89Cr -30.17L -26.3L -24.36L -22.81L -42.77L -28Cr -43.03L -1.12Cr -14Cr -1.13Cr -1.11Cr -49Cr 24L 3L 2L 2L 2L 4L 2.36Cr 4L 9L 1.16Cr 9L 9L 4.04Cr
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
18/26/18 0.2490 kr -1.19% 11,80,448
17/26/17 0.2520 kr +1.20% 3,09,898
16/26/16 0.2490 kr -1.97% 11,05,197
15/26/15 0.2540 kr -0.78% 7,23,102

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!